Insys Agrees to $225 Million Settlement of U.S. Claims of Illegal Opioid Sales

Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to settle U.S. claims that the drug maker illegally sold opioid-based painkillers. Under terms of the deal, Insys …

from News – Insurance Journal